BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 20085772)

  • 1. ODE models for oncolytic virus dynamics.
    Komarova NL; Wodarz D
    J Theor Biol; 2010 Apr; 263(4):530-43. PubMed ID: 20085772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards predictive computational models of oncolytic virus therapy: basis for experimental validation and model selection.
    Wodarz D; Komarova N
    PLoS One; 2009; 4(1):e4271. PubMed ID: 19180240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational modeling approaches to studying the dynamics of oncolytic viruses.
    Wodarz D
    Math Biosci Eng; 2013 Jun; 10(3):939-57. PubMed ID: 23906157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complex spatial dynamics of oncolytic viruses in vitro: mathematical and experimental approaches.
    Wodarz D; Hofacre A; Lau JW; Sun Z; Fan H; Komarova NL
    PLoS Comput Biol; 2012; 8(6):e1002547. PubMed ID: 22719239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mathematical model of oncolytic virotherapy with time delay.
    Wang ZZ; Guo ZM; Smith H
    Math Biosci Eng; 2019 Mar; 16(4):1836-1860. PubMed ID: 31137188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimal Control Model of Tumor Treatment with Oncolytic Virus and MEK Inhibitor.
    Su Y; Jia C; Chen Y
    Biomed Res Int; 2016; 2016():5621313. PubMed ID: 28097139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative imaging and dynamics of tumor therapy with viruses.
    Kemler I; Karamched B; Neuhauser C; Dingli D
    FEBS J; 2021 Nov; 288(21):6273-6285. PubMed ID: 34213827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computational modeling approaches to the dynamics of oncolytic viruses.
    Wodarz D
    Wiley Interdiscip Rev Syst Biol Med; 2016 May; 8(3):242-52. PubMed ID: 27001049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic viruses in cancer therapy.
    Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
    Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Questing for an optimal, universal viral agent for oncolytic virotherapy.
    Paiva LR; Martins ML; Ferreira SC
    Phys Rev E Stat Nonlin Soft Matter Phys; 2011 Oct; 84(4 Pt 1):041918. PubMed ID: 22181186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modelling heterogeneity in viral-tumour dynamics: The effects of gene-attenuation on viral characteristics.
    Jenner A; Yun CO; Yoon A; Kim PS; Coster ACF
    J Theor Biol; 2018 Oct; 454():41-52. PubMed ID: 29857083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the treatment of melanoma: A mathematical model of oncolytic virotherapy.
    Ramaj T; Zou X
    Math Biosci; 2023 Nov; 365():109073. PubMed ID: 37660975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach.
    Mahasa KJ; Eladdadi A; de Pillis L; Ouifki R
    PLoS One; 2017; 12(9):e0184347. PubMed ID: 28934210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The replicability of oncolytic virus: defining conditions in tumor virotherapy.
    Tian JP
    Math Biosci Eng; 2011 Jul; 8(3):841-60. PubMed ID: 21675814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of a Multiple Delays Model for Treatment of Cancer with Oncolytic Virotherapy.
    El Alami Laaroussi A; Hia ME; Rachik M; Ghazzali R
    Comput Math Methods Med; 2019; 2019():1732815. PubMed ID: 31662784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In silico evolutionary dynamics of tumour virotherapy.
    Reis CL; Pacheco JM; Ennis MK; Dingli D
    Integr Biol (Camb); 2010 Jan; 2(1):41-5. PubMed ID: 20473411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer gene therapy with oncolytic adenoviruses.
    Guse K; Hemminki A
    J BUON; 2009 Sep; 14 Suppl 1():S7-15. PubMed ID: 19785073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial Model for Oncolytic Virotherapy with Lytic Cycle Delay.
    Zhao J; Tian JP
    Bull Math Biol; 2019 Jul; 81(7):2396-2427. PubMed ID: 31089864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling oncolytic virotherapy: is complete tumor-tropism too much of a good thing?
    Okamoto KW; Amarasekare P; Petty IT
    J Theor Biol; 2014 Oct; 358():166-78. PubMed ID: 24810840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncolytic viral therapies and the delicate balance between virus-macrophage-tumour interactions: A mathematical approach.
    Almuallem N; Trucu D; Eftimie R
    Math Biosci Eng; 2020 Dec; 18(1):764-799. PubMed ID: 33525118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.